1p36.22 region containing PGD gene is frequently gained in human cervical cancer

Journal of Obstetrics and Gynaecology Research

Volumn 40, Issue 2, 2014, Pages 545-553

  Lee, Maria ^a   Nam, Eun Sook ^a   Jung, Seung Hyun ^b   Kim, Soon Young ^b   Lee, Sung Jong ^c   Yoon, Joo Hee ^c   Lee, Nak Woo ^e   Jeon, Seob ^f   Choi, Joong Sub ^d   Cho, Chi Heum ^g   Moon, Yong ^h   Chung, Yeun Jun ^b   Kwon, Yongil ^a  

^a Hallym University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Hanyang University College of Medicine   (South Korea)

^e Korea University   (South Korea)

^f Soonchunhyang University College of Medicine   (South Korea)

^g Dongsan Medical Center   (South Korea)

^h Namseoul University   (South Korea)

Author keywords

Array comparative genomic hybridization; Cervical cancer; Copy number alteration; PGD; Recurrently altered region

Indexed keywords

GENOMIC DNA; PHOSPHOGLUCONATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CHROMOSOME 1P; CHROMOSOME 1P36.22; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA REPLICATION; FEMALE; GENE DOSAGE; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KOREA; LYMPH NODE METASTASIS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VERY ELDERLY; CHEMISTRY; CHROMOSOME 1; COPY NUMBER VARIATION; GENETICS; SOUTH KOREA; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 1; DNA COPY NUMBER VARIATIONS; FEMALE; GENE DOSAGE; HUMANS; MIDDLE AGED; PHOSPHOGLUCONATE DEHYDROGENASE; REPUBLIC OF KOREA; UTERINE CERVICAL NEOPLASMS;

EID: 84897978996     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12193     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907.
3. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-935.
4. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet 2003; 33 (Suppl): 238-244.
5. Vissers LE, Veltman JA, van Kessel AG, Brunner HG. Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 2005; 14 (Spec No. 2): R215-R223.
6. Mantripragada KK, Buckley PG, Diaz de Stahl T, Dumanski JP. Genomic microarrays in the spotlight. Trends Genet 2004; 20: 87-94.
7. Kim MY, Yim SH, Kwon MS et al. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization. Gastroenterology 2006; 131: 1913-1924.
8. Kim TM, Yim SH, Shin SH et al. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer 2008; 123: 2808-2815.
9. Hidalgo A, Baudis M, Petersen I et al. Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. BMC Cancer 2005; 5: 77.
10. Rao PH, Arias-Pulido H, Lu XY et al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 2004; 4: 5.
11. Umayahara K, Numa F, Suehiro Y et al. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 2002; 33: 98-102.
12. Heselmeyer K, Macville M, Schrock E et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 1997; 19: 233-240.
13. Cooke SL, Temple J, Macarthur S et al. Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. Br J Cancer 2011; 104: 361-368.
14. Jung SH, Shin SH, Yim SH, Choi HS, Lee SH, Chung YJ. Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array. Exp Mol Med 2009; 41: 462-470.
15. Kim JH, Hu HJ, Yim SH, Bae JS, Kim SY, Chung YJ. CNVRuler: A copy number variation-based case-control association analysis tool. Bioinformatics 2012; 28: 1790-1792.
16. Jung SH, Lee A, Yim SH, Hu HJ, Choe C, Chung YJ. Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer. BMC Cancer 2012; 12: 382.
17. Yim SH, Kim TM, Hu HJ et al. Copy number variations in East-Asian population and their evolutionary and functional implications. Hum Mol Genet 2010; 19: 1001-1008.
18. Allen DG, White DJ, Hutchins AM et al. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 2000; 83: 1659-1663.
19. Dellas A, Torhorst J, Jiang F et al. Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization. Cancer Res 1999; 59: 3475-3479.
20. Heselmeyer K, Schrock E, du Manoir S et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996; 93: 479-484.
21. Shin SH, Shin GW, Yim SH, Jung SH, Jung GY, Chung YJ. Strategy for high-fidelity multiplex DNA copy number assay system using capillary electrophoresis devices. Electrophoresis 2011; 32: 1837-1843.
22. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, Jonasson JG, Egilsson V, Ingvarsson S. Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survival. Br J Cancer 1999; 79: 1468-1474.
23. Raish M, Khurshid M, Ansari MA et al. Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization. J Cancer Res Clin Oncol 2012; 138: 1173-1186.
24. Chattopadhyay I, Singh A, Phukan R et al. Genome-wide analysis of chromosomal alterations in patients with esoph-ageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat Res 2010; 696: 130-138.
25. Chang CC, Zhou X, Taylor JJ et al. Genomic profiling of plas-mablastic lymphoma using array comparative genomic hybridization (aCGH): Revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol 2009; 2: 47.
26. Choi YW, Bae SM, Kim YW et al. Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer 2007; 17: 687-696.
27. Narayan G, Bourdon V, Chaganti S et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overex-pressed genes. Genes Chromosomes Cancer 2007; 46: 373-384.
28. Hirai Y, Kawamata Y, Takeshima N et al. Conventional and array-based comparative genomic hybridization analyses of novel cell lines harboring HPV18 from glassy cell carcinoma of the uterine cervix. Int J Oncol 2004; 24: 977-986.
29. Sukhatme VP, Chan B. Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. FEBS Lett 2012; 586: 2389-2395.
30. Nilson B, Andersch B, Hansson G, Heyden G. Histochemical investigation of cervical intraepithelial neoplasia. Arch Gynecol 1987; 240: 75-79.
31. Jonas SK, Benedetto C, Flatman A et al. Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. Br J Cancer 1992; 66: 185-191.
32. Filosa S, Fico A, Paglialunga F et al. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem J 2003; 370 (Pt 3): 935-943.
33. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J 1995; 14: 5209-5215.
34. Aleman A, Cebrian V, Alvarez M et al. Identification of PMF1 methylation in association with bladder cancer progression. Clin Cancer Res 2008; 14: 8236-8243.
35. Mullighan CG, Miller CB, Radtke I et al. BCR-ABL1 lympho-blastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453: 110-114.